From 5524bcdb6e97d2d3a893df7504de842319960606 Mon Sep 17 00:00:00 2001
From: derekwong90 <78445989+derekwong90@users.noreply.github.com>
Date: Fri, 24 May 2024 08:28:57 -0400
Subject: [PATCH] Update README.md

---
 README.md | 2 ++
 1 file changed, 2 insertions(+)

diff --git a/README.md b/README.md
index 78a137b..4ccdeb4 100644
--- a/README.md
+++ b/README.md
@@ -2,6 +2,8 @@
 
 This repository is for code to reproduce analyses and figures for the manuscript: Cell-free DNA from germline TP53 mutation carriers reflect cancer-like fragmentation patterns
 
+Scripts for fragmentomic analyses can be found here: https://github.com/pughlab/fragmentomics
+
 # Abstract
 Germline pathogenic TP53 variants predispose individuals to a high lifetime risk of developing multiple cancers and are the hallmark feature of Li-Fraumeni Syndrome (LFS). Our group has shown shorter cell-free DNA fragmentation, independent of cancer status, in LFS individuals. To understand the functional underpinning of cfDNA fragmentation in LFS, we conducted a fragmentomic analysis of 199 cfDNA samples from 82 TP53 mutation carriers and 30 healthy TP53-wildtype controls. We find that LFS individuals exhibit an increased prevalence of A/T nucleotides at fragment ends, dysregulated nucleosome positioning at p53 binding sites, and loci-specific changes in chromatin accessibility at development-associated transcription factor binding sites and at cancer-associated open chromatin regions. Machine learning classification resulted in robust differentiation between TP53 mutant versus wildtype cfDNA samples (AUC-ROC = 0.710–1.000) and intra-patient longitudinal analysis of ctDNA fragmentation signal enabled early cancer detection. These results suggest that cfDNA fragmentation may be a useful diagnostic tool in germline negative LFS patients and provides an important baseline for cancer early detection.